Life science tools company Partillion Bioscience Corporation announced on Monday that it has started taking pre-orders for its Nanovial Multicell Assay Antibody Discovery Kits.
The Multicell Assay platform, which enables the co-loading of cell pairs to study cell-to-cell interactions, has been named a finalist for the Society for Laboratory Automation and Screening (SLAS) 2025 New Product Award.
At SLAS 2025, Partillion will showcase its Nanovial Multicell Antibody Discovery Kits which leverage larger 50 micrometre diameter EZM Nanovials to enable loading of target cells and antibody-secreting cells together, unlocking the ability to screen hundreds of thousands of antibody secreting cells based on antibody binding on a target cell for therapeutic development.
This platform builds on the success of Partillion's original Nanovial format, which earned the SLAS New Product Award in 2022.
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits
Samsung Biologics honoured at 2026 CDMO Leadership Awards
Frost & Sullivan names Abzena a market-leading ADC CDMO
Vulcan Two signs five-year ERP licence agreement to support ePharmacy expansion
SportsMed Physical Therapy named Physical Therapy Company of the Year
Ensorcell adds new senior leadership team members
GelMEDIX completes USD13m seed financing, announces first partnership
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme